MedPath
FDA Approval

Nilutamide

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
September 18, 2020
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Nilutamide(150 mg in 1 1)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Nilutamide

Product Details

NDC Product Code
62559-173
Application Number
ANDA207631
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
September 18, 2020
Code: 51G6I8B902Class: ACTIBQuantity: 150 mg in 1 1
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
POVIDONE K30Inactive
Code: U725QWY32XClass: IACT
DOCUSATE SODIUMInactive
Code: F05Q2T2JA0Class: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT
CALCIUM STEARATEInactive
Code: 776XM7047LClass: IACT
© Copyright 2025. All Rights Reserved by MedPath